Overview

Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
A study to use in home technology to reduce the burden of in office visits and injections.
Phase:
Phase 4
Details
Lead Sponsor:
Retinal Consultants of Arizona
Collaborator:
Genentech, Inc.
Treatments:
Ranibizumab